Glycosidic enzymes enhance retinal transduction following intravitreal delivery of AAV2.

Abstract

AAV2-mediated retinal transduction is improved by co-injection of heparinase III or chondroitin ABC lyase. Improved transduction efficiency may allow intravitreal injection to become the preferred route for delivering gene therapy to both the inner and outer retina.